comparing 7 ADHD telehealth services on published policy and price Sponsor RxGrab →
COMPARISON · ADHD TELEHEALTH · PUBLISHED POLICY AND PRICE

ADHD telehealth in 2026: who can actually prescribe a stimulant, and what it costs

Every other question about this category is downstream of one federal rule, and that rule has an expiry date on it. We compared seven services on what each one publishes about prescribing controlled substances and on what each one publishes as its price. No clinical claims, no rankings we cannot show you the basis for.

Services Compared
7
Named in full below
Rule Expires
31 Dec 2026
Federal Register 2025-24123
Sources Cited
7
DEA, DOJ, provider pages
Paid Links
None
No provider pays us
RXGRAB/PHARMACIES/ADHD TELEHEALTH
Updated September 17, 2026
How this comparison was built, and what it deliberately does not claim. This page compares what each service publishes: its stated policy on prescribing controlled substances, and its stated price. We have not enrolled in these services, paid their fees, or been evaluated or prescribed anything by them, and we make no claim about whether any particular pharmacy will fill any particular prescription. Whether a Schedule II prescription gets filled is decided by a pharmacist, in a state, for a patient, on a day, and no comparison page can settle that for you in advance. What a page can do is tell you what the rules are, what each service says it does, and what each one charges. That is what this one does.

01 / 06The rule the whole category runs on, and its expiry date

ADHD telehealth exists in its current form because of a temporary federal accommodation, not a permanent one. Since 12 May 2023, a DEA-registered practitioner has been permitted to prescribe Schedule II through V controlled substances by telemedicine without ever having conducted an in-person evaluation, provided the conditions in the regulation are met. Adderall, Vyvanse and Concerta are Schedule II. That accommodation is the reason an online ADHD prescription is possible at all.

The date that matters. On 31 December 2025 the DEA and HHS published the Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications, carrying the current arrangement through 31 December 2026. It is the fourth extension, each one temporary, with a permanent framework still in rulemaking. If you are choosing a service in 2026, you are choosing one whose ability to prescribe your medication the way it does today has a published end date. That is not a prediction on our part. It is the date printed in the rule.

Two things follow from that, and they are the reason this page is organised the way it is. First, a service that leans entirely on remote Schedule II prescribing carries a regulatory dependency that a service built around insurance-billed psychiatry or non-stimulant options does not. Second, several providers already behave more conservatively than the current rule requires, which tells you something about how they expect it to end. You can read that caution directly in their own published wording, and we quote it below rather than paraphrasing it.

02 / 06What happened to Done, from the public record

Any honest comparison of this category has to deal with the largest enforcement action in it, because one of the best-known names in online ADHD care was prosecuted. We are relying entirely on the Department of Justice's own published announcements here, and linking them, because this is a matter of court record rather than something a pricing site should be characterising on its own authority.

A federal grand jury in San Francisco indicted Done Global and an associated medical practice over what DOJ described as a years-long scheme to illegally distribute Adderall over the internet, together with health care fraud and obstruction charges. The company's founder and chief executive and its clinical president were subsequently convicted, and in July 2026 they were sentenced, the founder to 72 months and the clinical president to 24 months. DOJ's account describes the distribution of over 37 million pills of Adderall and more than $12 million defrauded from insurers.

Done continues to operate and still publishes a price, so it stays in the table below. We are not going to quietly drop a company from a comparison and leave you to find out why elsewhere, and we are not going to invent a measurement to justify a verdict either. The record is linked; it is a great deal more informative than any score we could put next to it.

03 / 06The seven, side by side

Every figure and every quotation below was read from the provider's own live pages on 17 September 2026. Where a provider states a condition on its prescribing, we quote the condition rather than reducing it to a tick.

ServiceWhat it publishes about controlled substancesSelf-pay priceWith insuranceModel
Talkiatry Psychiatrist-led care; lists Adderall (amphetamine) and Concerta (methylphenidate) among the medications it covers not published around $30 per visit insurance psychiatry
Brightside Health “In select states, Brightside providers may prescribe stimulants when appropriate for members based on their independent clinical judgment.” Also offers non-stimulant alternatives not published $25 or less insurance psychiatry
Circle Medical Primary care practice, in-network with many insurers; ADHD handled within general primary care $120 first visit, $120 follow-up about $35 average primary care
ADHD Online States treatment may involve medications that are “generally Class II controlled substances”, and only “if clinically appropriate based on a diagnosis” $219 assessment, or 3 payments of $73; $185 to $220 per treatment appointment varies assessment first
Klarity Health “Prescriptions, particularly for controlled substances, may require an in-person evaluation depending on the state of residence and current federal regulations” from $49 varies by provider marketplace
Talkspace Therapy-led platform with psychiatry available; stimulant prescribing is not a headline of its published offer therapy plans from $69 per week $0 copay for most insured members therapy first
Done Membership model. See section 02: its founder and clinical president were convicted and sentenced in a federal Adderall distribution and health care fraud prosecution $79 per month after the initial appointment; states medication costs of $40 to $80 per month without insurance not published membership

Two services that appeared in an earlier version of this page are not in the table, and we would rather say so than quietly shorten the list. Cerebral and Hims both returned bot-protection challenges or JavaScript-only pages to us, so we could not read a current published policy or price from either. That is a limitation of our access on the day, not a finding about those companies, and we are not going to characterise a service we could not read.

04 / 06Three models, and they produce three different bills

The seven services are not variations on one product. They are three business models, and which one suits you depends far more on your insurance than on any ranking.

Model 01

Insurance-billed psychiatry

Talkiatry and Brightside bill your insurer and you pay a copay. Published figures are around $30 and $25 or less respectively. If you are insured, this is usually the cheapest route and the one with the most clinical depth behind it.

$25BRIGHTSIDE, WITH INSURANCE
Model 02

Pay per visit

Circle Medical and ADHD Online charge for the appointment. Circle Medical publishes $120 self-pay; ADHD Online charges $219 for the assessment before treatment appointments at $185 to $220. You are buying clinician time, not a subscription.

$219ADHD ONLINE ASSESSMENT
Model 03

Monthly membership

Done charges $79 a month after the initial appointment, with medication on top. Klarity is a marketplace starting at $49 where the individual provider sets the price. The monthly number looks small and is not the whole bill.

$79DONE, PER MONTH

The arithmetic that catches people out is the same one as everywhere else in this category: a $79 monthly membership is $948 a year before a single tablet, while a $25 copay on an insurance-billed psychiatrist seen monthly is $300. If you have coverage, start there. We take the general version of that comparison apart in our guide to getting a prescription without insurance.

05 / 06Who should not use ADHD telehealth

06 / 06Method, and what we did not do

We read each provider's own published pages on 17 September 2026 and recorded their stated prices and their stated policy on controlled substances, quoting the policy wording rather than summarising it. Where a provider does not publish a figure, the cell says not published rather than carrying an estimate. Where we could not read a provider at all, it is named as excluded and the reason is given.

We did not enrol in any of these services, pay any fee, complete any evaluation, or obtain any prescription, and we did not attempt to fill a prescription at any pharmacy. An earlier version of this article described exactly those things. It should not have, and the claims have been removed rather than softened. Nothing on this page is medical advice, and no part of it should be read as a prediction that any particular pharmacy will fill any particular prescription.

The regulatory material is all primary and all linked: the current extension is in the Federal Register, the enforcement record is in the Department of Justice's own announcements, and the DEA's Diversion Control Division publishes the standing telemedicine position. If any figure here is wrong, those are the places it will show.

For the cash price of the prescription itself once you hold one, state prescription assistance programmes are worth checking, and Health Britannica covers the condition rather than the vendors.

Sources cited · this article7
  1. Drug Enforcement Administration and HHS. Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications, published 31 December 2025, effective through 31 December 2026.
  2. DEA Diversion Control Division. Telemedicine. Standing guidance on prescribing controlled substances by telemedicine encounter.
  3. U.S. Department of Justice. Digital Health Company and Medical Practice Indicted in $100M Adderall Distribution Scheme.
  4. U.S. Department of Justice. Founder/CEO and Clinical President of Digital Health Company Convicted.
  5. U.S. Department of Justice. Founder/CEO and Clinical President Sentenced, July 2026.
  6. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th Edition, Text Revision (DSM-5-TR), the diagnostic standard these services assess against.
  7. Provider pricing and policy pages. Linked inline in the comparison table above, each read on 17 September 2026.
Questions people actually ask

Can a telehealth doctor prescribe Adderall in 2026?

Under the current federal extension, a DEA-registered practitioner may prescribe Schedule II controlled substances by telemedicine without a prior in-person evaluation, provided the conditions in the regulation are met. That arrangement runs through 31 December 2026. State law can be stricter, and several providers on this page state their own additional conditions.

Will my pharmacy fill a prescription from an online provider?

That is decided by the pharmacist, under state law, for your specific prescription. We do not publish a fill rate, because we have not measured one and a number we cannot stand behind would be worse than none. If a pharmacy declines, ask your prescriber rather than abandoning the prescription.

Which is cheapest?

On published self-pay price, Klarity from $49. On published insured price, Brightside at $25 or less. If you have psychiatric coverage, an insurance-billed route will usually beat every self-pay option here.

Why is Done still listed after the convictions?

Because it still operates and still publishes a price, and because dropping it silently would tell you less than listing it with the court record attached. The DOJ announcements are linked in full above so you can read them rather than take our characterisation of them.